·   Log in

Archive for May 22nd, 2010

Abbott deal: Piramal to stop selling generic medicines in India for next 8 years

Saturday, May 22, 2010 9:04

India's fourth largest drug maker Piramal Healthcare Ltd would stop making generic medicine formulations for domestic market for the next 8 years following its acquisition by US firm Abbott Laboratories.

This was posted under category: Industry  |  Read Full Story  |  0 Comments

Abbott aims No 1 slot in Indian drug market combining Piramal’s formulations portfolio

Saturday, May 22, 2010 5:29

Piramal is currently India's 4th largest player with market-leading branded generics

This was posted under category: Featured, Industry  |  Read Full Story  |  0 Comments